The College on Problems of Drug Dependence recently announced the recipients of the 2025 Travel Awards. Each recipient will receive travel funds toward their attendance at this year’s meeting. Congratulations to all recipients.
The Stephen G. Holtzman Travel Award for Preclinical Investigators: This Travel Award was established by family & friends of Dr. Holtzman to honor his memory in tribute to his long-time service and dedication to the College on Problems of Drug Dependence. This award is given annually or biannually to either a predoctoral student or postdoctoral trainee involved in preclinical research related to substance abuse and dependence.
- Eleanor Blair Towers, Ph.D.
CPDD Travel Award for Early Career Investigators: This CPDD Travel Award is given to early career investigators (pre-doctoral students enrolled in a Ph.D. program and post-doctoral scientists within 5 years of terminal degree) to attend the CPDD Annual Scientific Meeting.
- Liam Acheson, Ph.D.
- Elaheh Ahounbar, M.Sc.
- Aeriell Armas, Ph.D.
- Katie Bailey, M.P.P, Ph.D.
- Amrit Baral, M.D., M.P.H., Ph.D.
- Justin Bell, Ph.D.
- Nicole Boss, M.A.
- Daniela Chiloff, M.D.
- Karen Choe
- Deja Clement, M.P.H., Ph.D.
- Jack Cordes, Ph.D., M.S.
- Alexa D'Angelo
- Ashley Dowd, Ph.D.
- Devin Effinger, Ph.D.
- Nicole Fitzgerald, Ph.D.
- Kimberly Gannon, B.S.
- Fernanda Gushken, M.D., M.P.H., M.S.
- Hector Gutierrez, B.S., M.S.
- Lalchhandama Hauhnar, MBA, M.D.
- Ariel Hoadley, M.P.H., Ph.D.
- Bryan Jenkins, M.Sc., Ph.D.
- Jada Johnson, M.S.
- Yousef Khan, B.S
- Mehrdad Khezri, M.Sc.
- Alexandra Knerr, Ph.D.
- Robert LeComte, Ph.D.
- Yoonjae Lee, DNP, APRN
- Amanda Liberman, M.D.
- Tatiana Magri, M.S.
- Lea Marineau, Ph.D.
- Theresa Matson, M.P.H., Ph.D.
- Tara McCrimmon, Dr. Ph., MPH, MIA
- Fahimeh Mohebbi, M.Sc.
- Andrew Moore, Ph.D.
- Shannon Ogden, M.P.H., Ph.D.
- Olajumoke Olarewaju, B.A., M.A.
- Alisson Paredes Naveda, M.A.
- Anna Parlier-Ahmad, B.S., M.S.
- Dan Petrovitch, M.A.
- Oluwaseyi Quadri, M.P.H.
- Brianna Roberts, B.S.
- Mia Rough, Ph.D.
- Maya Schumer, Ph.D.
- Luis Segura, M.D., M.P.H., Ph.D.
- Nima Shariatzadeh, B.S.
- Anjalee Sharma, M.S.W., Ph.D.
- Akshika Sharma, Ph.D.
- Jennifer Shipley, Ph.D., M.P.H.
- Kate Shirley, Ph.D.
- Sophia Solan, MPS
- Biyyiah Strickland, MSN, RN, PAHM
- Samuel Stull, Ph.D.
- Samuel Tetteh-Quarshie, Ph.D.
- Halle Thomas, B.S., M.A., Ph.D.
- Mireia Triguero Roura, Ph.D.
- Vivian Tsang, M.D.
- Claire Walsh, M.A.
- Christina Wysota, M.P.H., Ph.D.
- Kevin Yang, M.D.
- Ziping Ye, Ph.D.
- Zihan Zhang
- David T. Zhu, BSc
- Lalfak Zuali, M.Sc.
The CPDD International Travel Award: The National Institute on Drug Abuse (NIDA) and the College on Problems of Drug Dependence (CPDD) support an International Travel Award for substance abuse researchers from low-income, lower-middle-income, or upper middle-income countries (as defined by the World Bank) to participate in the NIDA International Forum (a satellite meeting of CPDD), the CPDD Annual Scientific Meeting, and associated research training activities.
- Marcelo Lima, M.D.
- Awoke Mihretu, Ph.D.
- Vinit Patel, M.D.
- Paola Palombo, Ph.D.
NIDA Director’s Travel Award: The National Institute on Drug Abuse (NIDA) anticipates supporting approximately 20 early career investigators to attend the Annual Scientific Meeting of CPDD with the NIDA Director’s Travel Award program The purpose of the award is to help defray the cost of attending CPDD for promising young scientists supported by NIDA training or career development grants.
- Erin Annunziato, M.P.H.
- Rebecca Bilden, Ph.D., M.Sc.
- Mark Britton, Ph.D.
- Megan Curis, M.D., M.S.
- Amanda Dorsey, Ph.D. Candidate
- Autumn Rae Florimbio, Ph.D.
- Jillian Giannini, M.A.
- Nathan Hager, Ph.D.
- Patrick Kelly, M.P.H.
- Wayne Kepner, M.P.H., Ph.D.
- Emily A Levine, B.A.
- Sarah Mixson, M.P.D.
- Tanya Pareek, Ph.D.
- Zachary Pierce-Messick, Ph.D.
- Jarratt Pytell, M.D.
- Alexandra Skinner, M.P.H.
- Emma Skogseth, M.S.
- Kaitlin Zinsli, M.P.H., Ph.D.
MySafeRX Inc. Technology-Based Treatments for Addiction Travel Award: MySafeRx Inc. is a nonprofit organization established to advance scientific research on the development, implementation, and dissemination of technological solutions for addiction treatment and medication adherence. Technology-based interventions represent an expanding area of scientific inquiry in addiction research. Rigorous study of these approaches builds the clinical evidence base and identifies priorities for future research. This work also evaluates how technological innovations may improve patient–provider communication, enhance data quality, and enable more timely interventions. By investing in the science that generates these solutions, MySafeRx Inc. seeks to advance knowledge that improves clinical outcomes and strengthens the healthcare system’s ability to respond to the complex challenges of addiction with agility and precision.
- Ghazaleh Soleimani, Ph.D.